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Abstract
Background:  While many Complementary/Alternative Medicine (CAM) practitioners do not object to
immunization, some discourage or even actively oppose vaccination among their patients. However, previous
studies in this area have focused on childhood immunizations, and it is unknown whether and to what extent CAM
practitioners may influence the vaccination behavior of their adult patients. The purpose of this study was to
describe vaccination coverage levels of adults aged ≥ 18 years according to their CAM use status and determine
if there is an association between CAM use and adult vaccination coverage.
Methods: Data from the 2002 National Health Interview Survey, limited to 30,617 adults that provided at least
one valid answer to the CAM supplement, were analyzed. Receipt of influenza vaccine during the past 12 months,
pneumococcal vaccine (ever), and ≥ 1 dose of hepatitis B vaccine was self-reported. Coverage levels for each
vaccine by CAM use status were determined for adults who were considered high priority for vaccination because
of the presence of a high risk condition and for non-priority adults. Multivariable analyses were conducted to
evaluate the association between CAM users and vaccination status, adjusting for demographic and healthcare
utilization characteristics.
Results: Overall, 36% were recent CAM users. Among priority adults, adjusted vaccination coverage levels were
significantly different between recent and non-CAM users for influenza (44% vs 38%; p-value < 0.001) and
pneumococcal (40% vs 33%; p-value < 0.001) vaccines but were not significantly different for hepatitis B (60% vs
56%; p-value = 0.36). Among non-priority adults, recent CAM users had significantly higher unadjusted and
adjusted vaccination coverage levels compared to non-CAM users for all three vaccines (p-values < 0.001).
Conclusion: Vaccination coverage levels among recent CAM users were found to be higher than non-CAM
users. Because CAM use has been increasing over time in the U.S., it is important to continue monitoring CAM
use and its possible influence on receipt of immunizations among adults. Since adult vaccination coverage levels
remain below Healthy People 2010 goals, it may be beneficial to work with CAM practitioners to promote adult
vaccines as preventive services in keeping with their commitment to maintaining good health.
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Background
Complementary and alternative medicine (CAM) is the
collective term for treatments and therapies not routinely
offered by mainstream medical practitioners, or widely
taught at U.S. medical schools [1]. This broad definition
encompasses a range of both provider and non provider-
based interventions, from chiropractic and homeopathy
to herbs and nutritional supplements. A recent analysis of
the Alternative Health/Complementary and Alternative
Medicine supplement of the 2002 National Health Inter-
view Survey (NHIS) found that 75% of adults in the U.S.
have ever used some type of CAM therapy, including
prayer specifically for health reasons [2]. There is also evi-
dence to suggest that the proportion of U.S. adults who
report CAM use has been increasing over time [3].
Reasons for CAM use vary, but generally fall into two cat-
egories which reflect both the complementary and alter-
native nature of these therapies. Some people use CAM as
a complement to their regular medical care, either to
improve general health and wellness or as an adjunct to
treatment for chronic illnesses like back pain [4]. Others
prefer CAM as an alternative to mainstream medicine, cit-
ing dissatisfaction with mainstream medicine as their pri-
mary reason for use [4]. Whatever the reason for its use,
many of those who use CAM in addition to conventional
medical care do not report CAM use to their primary care
physician [3,5]. This creates the potential for conflict, as
CAM therapies may negatively interact with treatment, or
contradictory advice from CAM practitioners may influ-
ence acceptance of or adherence to medical advice.
Influenza, pneumococcal, and hepatitis B vaccines are all
recommended for certain segments of the adult popula-
tion, depending on age and risk factors for each disease
[6]. These illnesses represent a substantial burden of vac-
cine-preventable disease in the United States; however,
influenza and pneumococcal immunization rates for tar-
get groups remain below Healthy People 2010 goals, and
achievement of high hepatitis B vaccination rates among
high risk adults remains a challenge [7,8]. Poor access to
healthcare, low awareness of recommendations, and
safety concerns are all reasons for undervaccination
among adults, while physician recommendation has been
cited as an important factor in acceptance of adult immu-
nization [9-11].
It has been suggested that while many CAM practitioners
do not object to immunization, some discourage or even
actively oppose vaccination among their patients [12-14].
However, previous studies in this area have focused on
childhood immunizations, and it is unknown whether
and to what extent CAM practitioners may negatively
influence the vaccination behavior of their adult patients.
Conversely, adult CAM users may be more likely to accept
vaccination, as CAM use may act as a signal that an indi-
vidual is highly engaged in maintaining their health, and
therefore more motivated to accept preventive services.
Determining which is the most likely of these two scenar-
ios is of significant public health importance given the
growing popularity of CAM therapies and the continued
burden of vaccine-preventable disease among U.S. adults.
Therefore, the objectives of this study were to: 1) describe
the influenza, pneumococcal, and hepatitis B immuniza-
tion coverage levels of adults 18 years and older in the
United States according to their CAM use status and 2)
determine if there is an association between CAM use and
immunization coverage among priority and non-priority
adults for each vaccine. To our knowledge, this is the first
nationally representative study to examine the association
between CAM use and immunization behavior among
adults in the U.S.
Methods
National Health Interview Survey (NHIS)
The NHIS is an annual survey conducted by the National
Center for Health Statistics (NCHS), Centers for Disease
Control and Prevention (CDC) that collects health infor-
mation on the U.S. civilian, non-institutionalized house-
hold population. The sampling design employs a
multistage area probability design; non-Hispanic black
and Hispanic populations are oversampled to allow for
more precise estimates of health status in these groups. In
2002, the Alternative Health/Complementary and Alter-
native Medicine (CAM) supplement was administered to
one randomly selected adult per family. The supplemen-
tal questionnaire included questions on 27 types of CAM
therapies commonly used in the United States. A com-
plete description of the supplement can be found else-
where [2,15]. The final sample adult response rate was
73.4%.
Alternative Health/Complementary and Alternative 
Medicine
Analysis was limited to the 30,617 adults that provided at
least one valid answer to the CAM supplement [16]. CAM
therapies were classified according to Barnes et al [2] as
practitioner-based (i.e. acupuncture; ayurveda; biofeed-
back; chelation therapy; chiropractic care; folk medicine;
hypnosis; massage; naturopathy; and energy healing ther-
apy/Reiki) and non-practitioner-based (i.e. natural herbs
such as ginger, Echinacea, or black cohosh; homeopathic
treatment; high dose or megavitamin therapy; special
diets such as vegetarian, macrobiotic, Atkins, Pritikin,
Ornish, and Zone; Yoga/Tai Chi/Qi Gong; and relaxation
techniques such as meditation, guided imagery, progres-
sive relaxation, and deep breathing exercises). Respond-
ents who indicated they had used any of the previously
listed CAM therapies during the past 12 months were con-
sidered 'Recent' CAM users; respondents who indicatedBMC Complementary and Alternative Medicine 2008, 8:6 http://www.biomedcentral.com/1472-6882/8/6
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they have used one or more CAM therapies but not in the
past 12 months were considered 'Past' CAM users; 'Never'
CAM users included persons who indicated they have
never used any CAM therapies.
Vaccination Status
The 2002 NHIS included questions in the adult question-
naire about three vaccines: influenza, pneumococcal, and
hepatitis B. Respondents were asked if they had received a
'flu shot' during the past 12 months, if they had ever
received a 'pneumonia shot', and if they had ever received
a dose of the hepatitis B vaccine. Vaccination status was
self reported by the respondent and was not verified by a
provider. Respondents who answered "Don't know" or
refused to answer the vaccination questions (0.5% for
influenza vaccine; 2.7% for pneumococcal vaccine; 5.6%
for hepatitis B vaccine) were excluded from the analysis
for the vaccine of interest.
For each vaccine, respondents were categorized as 'prior-
ity' or 'non-priority' adults according to vaccine recom-
mendations from the Advisory Committee on
Immunization Practices [17-19]. A list of the criteria used
to categorize adults as 'priority' can be seen in Table 1. All
responses to NHIS questions regarding health care condi-
tions and occupation are self reported by the respondent.
Data analysis
Statistical analysis included estimating the proportion
and 95% confidence intervals of adults who are recent,
past, or never CAM users by demographic characteristics.
Estimated vaccination coverage levels for priority and
non-priority adults for influenza, pneumococcal, and
hepatitis B vaccines were also assessed by CAM use status
(unadjusted coverage levels). To evaluate the association
between CAM use and vaccination status, multivariable
analyses were conducted which adjusted for the demo-
graphic and healthcare utilization characteristics listed in
Table 2. Separate models were created for priority and
non-priority adults for each of the three vaccines of inter-
est (adjusted coverage levels). Independent variables were
tested for joint collinearity using condition indices, a
measure of multi-collinearity. Evaluation of condition
indices indicated little collinearity among variables in the
logistic regression models. Because previous studies have
suggested that some Chiropractors oppose vaccination
[14], we also evaluated vaccination coverage levels among
Chiropractic users.
Because NHIS is a complex survey that involves clustering,
stratification, and multistage sampling techniques to
obtain nationally representative information on the
health of the nation, all analyses were conducted using
SAS, release 8.0 (SAS Institute, Cary, NC, 2001) and
SUDAAN, release 9 (Research Triangle Institute, Research
Triangle Park, NC, 2001) to account for the survey sample
design in calculating the standard errors and confidence
intervals. The data file obtained from the NCHS included
the sample weights used in the analysis [16]. Categorical
independent variables were compared using the Chi-
square test. Multiple logistic regression and computation
of predictive margins were used to estimate the probabil-
ity of vaccination when controlling for all other independ-
ent variables. The predictive margin for each variable
included in the model along with the corresponding 95%
confidence interval was reported. Predictive margins are a
type of direct standardization that allows for the compar-
ison of group outcomes while controlling for the covariate
distribution in the population. They are best used when
the outcome is not rare (i.e. > 10%). They are easier to
interpret than odds ratios and allow for different compar-
isons to be made, as no referent group is designated
[20,21].
Results
CAM Use
Overall, 35.7% (± 0.7%) of adults 18 years and older were
recent CAM users, 42.6% (± 0.7%) were past CAM users,
and 21.7% (± 0.7%) were never CAM users. Among recent
CAM users, 13.6% (± 0.8%) used practitioner based ther-
apies, 66.9% (± 1.1%) used non-practitioner based thera-
pies, and 19.5% (± 0.9%) used both practitioner and non-
Table 1: Criteria used for classifying adults as high priority for receiving select vaccines
Vaccine Criteria
Influenza Age ≥ 50 years; ever had diabetes; ever had coronary heart disease, angina, myocardial infarction or some other heart 
condition; ever had emphysema, chronic bronchitis, or an asthma attack within the past 12 months; or, was diagnosed with 
cancer within the past 12 months
Pneumococcal Age ≥ 65 years; ever had diabetes; ever had coronary heart disease, angina, myocardial infarction or some other heart 
condition; ever had emphysema or chronic bronchitis; had weak kidneys during the past 12 months; had a liver condition in 
the past 12 months; or, was diagnosed with cancer within the past 12 months
Hepatitis B Was in a healthcare, police or fire occupation; reported having had a sexually transmitted infection other than HIV in the last 
5 years; considered their risk of getting HIV as "high/have AIDS" or "medium high"; or, they answered yes to being in any of 
the six hepatitis B risk groups (having hemophilia and received clotting factor concentrates, men who have had sex with men, 
ever used street drugs by needle, ever traded sex for money or drugs, ever tested positive for HIV, or ever had sex with 
someone in any of these groups)BMC Complementary and Alternative Medicine 2008, 8:6 http://www.biomedcentral.com/1472-6882/8/6
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Table 2: Demographic characteristics and vaccination status by Complementary/Alternative Medicine (CAM) use, 2002 National 
Health Interview Survey
Characteristic Recent CAM user (N = 10,867) Past CAM user (N = 12,781) Never CAM user (N = 6969)
# % (95% CI) # % (95% CI) # % (95% CI)
Sex
Female 6727 58.2 (± 1.1) 7154 51.3 (± 1.1) 3430 43.5 (± 1.4)
Age (years)
18–49 yrs 6834 65.0 (± 1.1) 7027 58.1 (± 1.2) 4550 68.1 (± 1.4)
50–64 yrs 2545 23.4 (± 0.9) 2725 21.8 (± 0.9) 1164 16.3 (± 1.0)
65+ yrs 1488 11.6 (± 0.7) 3029 20.0 (± 0.9) 1255 15.6 (± 0.9)
Race/ethnicity
NH-White 7686 76.8 (± 1.0) 8827 75.8 (± 1.1) 3532 60.5 (± 1.7)
NH-Black 1117 8.5 (± 0.7) 1632 10.6 (± 0.7) 1285 16.5 (± 1.3)
Hispanic 1459 8.5 (± 0.6) 1844 9.3 (± 0.7) 1904 18.7 (± 1.2)
NH-Other 605 6.2 (± 0.6) 478 4.4 (± 0.5) 248 4.4 (± 0.7)
Region
Northeast 2009 19.6 (± 1.0) 2333 19.1 (± 1.0) 1241 18.7 (± 1.3)
Midwest 2675 25.8 (± 1.4) 3091 25.6 (± 1.1) 1291 20.5 (± 1.6)
South 3460 31.6 (± 1.4) 4867 38.1 (± 1.2) 3000 43.6 (± 1.8)
West 2723 23.0 (± 1.4) 2490 17.2 (± 0.9) 1437 17.2 (± 1.2)
Education level
Less than High School 1186 9.5 (± 0.7) 2342 15.9 (± 0.8) 2335 30.1 (± 1.4)
High School or GEDa 2570 24.8 (± 1.1) 4021 32.4 (± 1.0) 2152 33.3 (± 1.3)
More than High School 7061 65.7 (± 1.2) 6310 51.7 (± 1.1) 2301 36.6 (± 1.6)
Poverty Status
Below poverty 985 6.5 (± 0.5) 1328 7.6 (± 0.6) 1088 12.1 (± 0.9)
At or above poverty, < 200% poverty 1375 10.7 (± 0.7) 1915 12.7 (± 0.7) 1284 16.6 (± 1.0)
At or above 200% poverty 6486 63.9 (± 1.1) 6419 55.0 (± 1.1) 2502 40.8 (± 1.5)
Unknown 2021 18.8 (± 0.9) 3119 24.7 (± 1.0) 2095 30.5 (± 1.5)
Smoking status
Current 2435 22.0 (± 1.0) 2727 21.3 (± 0.9) 1708 26.0 (± 1.3)
Former 2705 25.4 (± 1.1) 2953 23.5 (± 0.8) 1081 16.3 (± 1.1
Never 5706 52.6 (± 1.2) 7046 55.2 (± 1.0) 4047 57.6 (± 1.6)
# Dr. visits
0–1 visits 2933 27.2 (± 1.0) 4400 35.3 (± 1.0) 3394 50.2 (± 1.5)
2–9 visits 5659 53.2 (± 1.0) 6560 52.3 (± 1.1) 2782 40.9 (± 1.5)
10+ visits 2188 19.6 (± 0.9) 1698 12.4 (± 0.6) 666 8.9 (± 0.8)
Usual source of careb
Yes 9454 87.6 (± 0.7) 11121 88.0 (± 0.7) 5280 77.5 (± 1.2)
Priority for influenza vaccine
Yes 5211 45.9 (± 1.2) 6627 49.0 (± 1.2) 2852 38.5 (± 1.5)
Priority for pneumococcal 
vaccine
Yes 3238 27.5 (± 1.0) 4631 33.0 (± 1.1) 1968 26.0 (± 1.3)
Priority for hepatitis B vaccine
Yes 1407 12.5 (± 0.7) 1052 8.3 (± 0.6) 498 6.8 (± 0.7)
Insurance status
No Insurance 1537 13.2 (± 0.8) 1755 12.7 (± 0.7) 1782 24.2 (± 1.2)
Medicaid Only 447 3.1 (± 0.4) 595 3.8 (± 0.4) 600 7.0 (± 0.7)
Medicare Only 387 3.0 (± 0.4) 854 5.4 (± 0.5) 466 5.5 (± 0.6)
Single, Military, Other Pub/Govt, or 
IHS Only
229 1.8 (± 0.3) 288 2.0 (± 0.3) 160 2.1 (± 0.4)
Private Only 6217 61.0 (± 1.2) 6390 55.2 (± 1.1) 2932 47.1 (± 1.6)
Multiple Insurance 2050 17.8 (± 0.8) 2899 20.8 (± 0.9) 1029 14.0 (± 0.9)
Received influenza vaccine 3189 28.7 (± 1.0) 4165 31.4 (± 0.9) 1441 20.0 (± 1.1)
Received pneumococcal vaccine 1788 16.1 (± 0.8) 2513 18.4 (± 0.8) 771 10.9 (± 0.8)
Received hepatitis B vaccine 3066 30.1 (± 1.1) 2799 24.0 (± 1.0) 1206 19.5 (± 1.3)
aGED: General Educational Development
bFrom the question: "Is there a place that you usually go to when you are sick or need advice about your health?"BMC Complementary and Alternative Medicine 2008, 8:6 http://www.biomedcentral.com/1472-6882/8/6
Page 5 of 8
(page number not for citation purposes)
practitioner based therapies; 69.4% (± 1.1%) reported
that CAM use was somewhat or very important to main-
taining their health. Demographic characteristics of
recent, past, and never CAM users can be seen in Table 2.
Recent CAM users had a higher frequency of being female,
of being non-Hispanic white, living in the West Census
region, having greater than a high school education level,
living at or above 200% of the federal poverty level, mak-
ing 10 or more visits to the doctor during the past 12
months, being in the priority group for hepatitis B vac-
cine, and having only private health insurance.
Immunization Status
Unadjusted vaccination coverage
Among priority adults, overall vaccination coverage levels
were 43.1% (± 1.0%) for influenza, 39.0% (± 1.2%) for
pneumococcal, and 57.5% (± 2.2%) for hepatitis B vac-
cines. Unadjusted vaccination coverage levels by CAM use
can be seen in Table 3. Never CAM users had significantly
lower vaccination coverage levels for influenza, pneumo-
coccal, and hepatitis B vaccines compared to recent and
past CAM users. Past CAM users had significantly higher
vaccination coverage levels for influenza and pneumococ-
cal vaccines when compared to recent CAM users.
Among non-priority adults, overall vaccination coverage
levels were 15.3% (± 0.7%) for influenza, 6.3% (± 0.4%)
for pneumococcal, and 21.8% (± 0.8%) for hepatitis B
vaccines. Unadjusted vaccination coverage levels by CAM
use can be seen in Table 3. Recent CAM users had signifi-
cantly higher pneumococcal and hepatitis B vaccination
coverage levels compared to past CAM users and signifi-
cantly higher coverage for all three vaccines compared to
never CAM users. The largest difference in coverage was
observed for the hepatitis B vaccine, where recent CAM
users had coverage levels 8.3 percentage points higher
than never CAM users.
Adjusted vaccination coverage
In multivariable analyses adjusting for demographic and
health care utilization characteristics, the difference in
hepatitis B coverage levels for priority adults between
recent and never CAM users was no longer statistically sig-
nificant (Table 3). For non-priority adults, adjusted differ-
ences between recent, past and never CAM users remained
significant for influenza, pneumococcal, and hepatitis B
vaccines.
Table 3: Unadjusted and adjusteda vaccination coverage levels among priority and non-priority adults by CAM use, 2002 National 
Health Interview Survey
Influenza % (95% CI) Pneumococcal % (95% CI) Hepatitis B % (95% CI)
Priority Adults (n = 14,595) (n = 9,596) (n = 2,848)
Unadjusted results
CAM use
Recent 42.1 (40.6, 43.6) 37.6 (35.6, 39.5) 59.9 (56.7, 63.1)
Past 46.9 (45.5, 48.3)* 43.6 (42.0, 45.2)* 58.2 (54.8, 61.7)
Never 35.6 (33.4, 37.7)*+ 30.1 (27.8, 32.4)*+ 48.4 (42.8, 54.0)*+
Adjusted results
CAM use
Recent 43.5 (41.9, 45.1) 39.6 (37.6, 41.6) 59.5 (56.4, 62.6)
Past 44.4 (43.0, 45.8) 41.2 (39.6, 42.8) 58.2 (54.9, 61.5)
Never 38.2 (36.0, 40.4)*+ 32.7 (30.3, 35.1)*+ 56.4 (50.9, 61.9)
Non-Priority Adults (n = 15,927) (n = 20,328) (n = 26,179)
Unadjusted results
CAM use
Recent 17.3 (16.1, 18.5) 8.0 (7.2, 8.7) 25.7 (24.6, 26.9)
Past 16.4 (15.4, 17.5) 6.0 (5.4, 6.6)* 20.9 (19.8, 21.9)*
Never 10.3 (9.2, 11.4)*+ 4.1 (3.5, 4.8)*+ 17.4 (16.0, 18.7)*+
Adjusted results
CAM use
Recent 16.1 (14.9, 17.3) 7.6 (6.8, 8.4) 27.5 (26.1, 28.9)
Past 16.3 (15.3, 17.3) 6.0 (5.4, 6.6)* 25.6 (24.4, 26.8)*
Never 12.0 (10.6, 13.4)*+ 4.4 (3.6, 5.2)*+ 21.1 (19.5, 22.7)*+
* denotes significantly different than recent cam users; + denotes significantly different than past cam users
aMultivariable model adjusts for age, gender, race/ethnicity, education level, federal poverty level, region, having a usual source of care other than 
the emergency department, number of visits to a physician during the past 12 months, health insurance status, and smoking status.BMC Complementary and Alternative Medicine 2008, 8:6 http://www.biomedcentral.com/1472-6882/8/6
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Vaccination coverage among Chiropractic users
Overall, 19.8% (± 0.6%) of respondents reported ever
using Chiropractic services; 7.5% (± 0.4%) reported visit-
ing a chiropractor in the past 12 months and 12.3% (±
0.5%) reported visiting a chiropractor more than 12
months ago. Because of the small sample sizes among the
recent and past chiropractic use categories, we combined
the groups for the vaccination coverage analysis which can
be seen in Table 4. In general, persons who have reported
ever using chiropractic services had lower vaccination cov-
erage levels than non-chiropractic CAM users. However,
among priority adults, chiropractic users had significantly
higher vaccination coverage levels for influenza and pneu-
mococcal vaccines compared to never CAM users. Among
non-priority adults, chiropractic users had significantly
higher vaccination coverage levels for all vaccines com-
pared to never CAM users.
Discussion
Results from a nationally representative survey of U.S.
adults have shown that after adjusting for demographic
and healthcare utilization characteristics, coverage levels
for influenza and pneumococcal vaccines were signifi-
cantly higher among priority adults who were recent or
past CAM users compared to adults who had never used a
CAM therapy. Among non-priority adults, adjusted cover-
age levels for influenza, pneumococcal, and hepatitis B
vaccines were significantly higher among recent or past
CAM users when compared to never CAM users. Addition-
ally, adults using chiropractic services had higher vaccina-
tion coverage levels compared to never CAM users.
Results from this study are somewhat unexpected consid-
ering findings from previous studies have shown that par-
ents with an alternative medical orientation were
significantly less accepting of immunizations for their
children [22,23]. A national survey of parents of children
aged ≤ 6 years found that when compared to parents with
a conventional medical orientation, parents with an alter-
native medical orientation were significantly less likely to
believe immunizations are important (89.4% vs. 75.5%,
respectively) and more likely to choose to opt out of an
immunization for their child (11.2% vs. 24.9%, respec-
tively) [22]. In a study of parents of school children, par-
ents claiming vaccine exemptions for their children were
more likely than parents of vaccinated children to report
use of CAM professionals by their immediate family
members (79.6% vs. 51.2%, respectively) [23]. It could be
that parents are more cautious of vaccination for their
children because the hypothesized risks for children's
immunizations are more publicized and more severe [24]
than those for adult immunizations. Also, parents may be
more averse to risks that are involuntary (e.g., school entry
laws), and risks to children (that cause greater fear or
dread than risks to adults) [25,26].
Our results suggest that, similar to previous studies,
respondents use CAM as supplemental rather than alter-
native health care [4,27]. Recent and past CAM users in
our study were significantly more likely to have more doc-
tor visits than non-CAM users. Because CAM users tend to
have more doctor visits, they likely have more contact
with physicians which provide more opportunities to be
immunized. The positive association between CAM use
and immunization coverage among priority adults also
suggests that even if CAM users are receiving negative
information regarding immunizations from their CAM
providers, it is not affecting their receipt of immuniza-
tions at this time.
The difference in hepatitis B vaccination coverage levels
between recent and non-CAM users was relatively small
(i.e. 4–6 percentage points for priority and non-priority
adults) and remained significant among non-priority
Table 4: Adjusteda vaccination coverage levels of priority and non-priority adults by Chiropractic therapy use, 2002 National Health 
Interview Survey
Influenza % (95% CI) Pneumococcal % (95% CI) Hepatitis B % (95% CI)
Priority Adults (n = 14,595) (n = 9,596) (n = 2,848)
Chiropractic use
Use Chiropractic therapy 41.7 (39.9, 43.5) 40.3 (39.3, 42.7) 55.2 (50.3, 60.1)
CAM user, non-chiropractic 44.9 (43.7, 46.1)* 40.7 (39.3, 42.1) 60.1 (57.6, 62.6)
Never used CAM 38.3 (36.1, 40.5)*+ 32.6 (30.2, 35.0)*+ 56.7 (51.2, 62.2)
Non-Priority Adults (n = 15,927) (n = 20,328) (n = 26,179)
Chiropractic use
Use Chiropractic therapy 15.8 (14.2, 17.4) 6.9 (6.1, 7.7) 25.7 (23.9, 27.4)
CAM user, non-chiropractic 16.3 (15.3, 17.3) 6.7 (6.1, 6.7) 26.8 (25.8, 27.8)
Never used CAM 12.0 (10.6, 13.4)*+ 4.5 (3.7, 5.3)*+ 21.2 (19.6, 22.8)*+
* denotes significantly different than chiropractic users; + denotes significantly different than non-chiropractic CAM users
aMultivariable model adjusts for age, gender, race/ethnicity, education level, federal poverty level, region, having a usual source of care other than 
the emergency department, number of visits to a physician during the past 12 months, health insurance status, and smoking status.BMC Complementary and Alternative Medicine 2008, 8:6 http://www.biomedcentral.com/1472-6882/8/6
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adults after adjusting for demographic and healthcare uti-
lization characteristics. The finding that CAM users had
higher vaccination coverage levels for hepatitis B has sev-
eral possible explanations. First, CAM users might be
more concerned about their general health and wellness
[4] and therefore more likely to get all immunizations.
Another possible reason could be that CAM providers
request their patients to receive the hepatitis B vaccination
to protect themselves from liability in light of publicized
hepatitis B outbreaks among alternative medicine prac-
tices in which CAM procedures required injections
[28,29]. Notably, many CAM therapies are available for
persons with hepatitis B or hepatitis C disease, and HIV.
Thus populations at high risk for hepatitis B infection
might already be aware of the healing opportunities CAM
therapies may provide. In addition, hepatitis B is a sexu-
ally transmitted disease and thus those at risk for hepatitis
B may also be at risk for other STDs (e.g., HIV, chronic
vaginal symptoms). Studies have shown that persons with
some STDs use CAM therapies to alleviate symptoms
before they are diagnosed [30,31].
This study was subject to several limitations. The defini-
tion of CAM use was wide and included therapies that
some may consider mainstream and not alternative, such
as yoga or special diets like Atkins. The inclusion of these
more common and mainstream therapies could have less-
ened the difference seen in vaccination coverage between
CAM users and non-CAM users. Thus, the actual differ-
ence may be larger than observed. Immunization status
was self-reported and not verified by a medical provider;
however, a previous study found that self-report of influ-
enza and pneumococcal vaccinations are highly sensitive,
with moderate to low specificity, respectively [32]. Due to
the cross sectional nature of the study we could not assess
a temporal relationship and therefore we are not able to
establish causal relationships. It is unknown if vaccinated
respondents received their vaccines prior to or after initi-
ating a CAM therapy.
Conclusion
To our knowledge, this is the first nationally representa-
tive study to investigate a potential association of CAM
use among adults and the receipt of vaccination. Because
CAM use has been increasing over time in the U.S., it is
important to continue to monitor CAM use and its possi-
ble influence on receipt of immunizations among adults.
Since one-third of CAM users receive practitioner-based
therapies, and adult vaccination coverage levels remain
below Healthy People 2010 goals, it may be beneficial to
work with CAM practitioners to promote adult vaccines as
preventive services in keeping with their commitment to
maintaining good health. However, before this is under-
taken, a thorough understanding of the attitudes and
beliefs of CAM practitioners regarding adult vaccination
should be assessed.
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